Home/Filings/4/0001104659-22-019551
4//SEC Filing

Hinshaw William 4

Accession 0001104659-22-019551

CIK 0001633070other

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 6:03 PM ET

Size

7.7 KB

Accession

0001104659-22-019551

Insider Transaction Report

Form 4
Period: 2022-02-08
Hinshaw William
DirectorPresident and CEO
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-02-08+275,000275,000 total
    Exercise: $1.63Exp: 2032-02-07Common Stock (275,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2022-02-08+100,000100,000 total
    Exercise: $5.00Exp: 2032-02-07Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]25% of this option shall vest and become exercisable on February 8, 2023, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Issuer

Axcella Health Inc.

CIK 0001633070

Entity typeother

Related Parties

1
  • filerCIK 0001774662

Filing Metadata

Form type
4
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 6:03 PM ET
Size
7.7 KB